Chemoradiation
31
6
7
11
Key Insights
Highlights
Success Rate
85% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
6.5%
2 terminated out of 31 trials
84.6%
-1.9% vs benchmark
16%
5 trials in Phase 3/4
18%
2 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (31)
Testing Ramipril to Prevent Memory Loss in People With Glioblastoma
Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation
Neoadjuvant Treatment Modalities in Esophageal Cancer
Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer
PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant Chemotherapy
TNT to Increase the Clinical Complete Response Rate for Distal LARC
Organoid Based Response Prediction in Esophageal Cancer
Pre Radiotherapy Daily Exercise Training in Non-Small Cell Lung Cancer
Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCC
Chemoradiation Plus Tislelizumab for Conversion Therapy of Locally Nonresectable ESCC
Induction Chemotherapy Plus Chemoradiotherapy With or Without Aspirin in High Risk Rectal Cancer
S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal Cancer
Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01
European iNvestigation of SUrveillance After Resection for Esophageal Cancer
Comparison Between Wound Vacuum Dressing and Standard Closure to Reduce Rates of Surgical Site Infections
Organ Motion and Early Tumor Response Measurement
Oncologic Risk of Rectal Preservation Against Medical Advice After Chemoradiotherapy for Rectal Cancer
Prospective Observational Trial to Evaluate Quality of Life After Definitive Chemoradiation in Patients With Anal Cancer (LANACARE)
Definitive (Chemo)Radiotherapy for Patients With Esophageal Cancer - 3JECROG R-01
Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant Radiation or Chemoradiation Followed by Surgery in Patients With Rectal Cancer